2 April 2025
Talking Nutrition, Health & Care
Our latest articles, covering industry news, new science, consumer insights and more.
Featured story
How to fly from concept to consumer: Unlock 9 benefits of our Premix Solutions.
Our Premix Solutions offering can help customers streamline their product development and launch breakthrough health solutions that address consumer needs with sustainability at the core.
Discover nine advantages of leveraging our end-to-end Premix Solutions offering, from concept ideation to overcoming product development pitfalls and accelerating speed to market.
Latest Articles
-
-
12 February 2025
Unlock mineral bioavailability: How phytase breaks through absorption barriers
-
18 December 2024
What does the latest gut health research tell us about Humiome® B2’s potential for a healthy gut microbiome? Ask the scientist
-
14 August 2024
Ask the expert: how can ascorbic acid help mitigate nitrosamine risk in drug products?
-
5 August 2024
It takes guts and science: Unlock the latest research behind human milk oligosaccharides (HMOs) for human health
-
26 July 2024
Supercharge your odds of scientific success with the dsm-firmenich CBD API sampling program
-
26 July 2024
How to fly from concept to consumer: Unlock 9 benefits of our Premix Solutions
-
26 July 2024
Highlights from ACOG: New guidelines for omega-3 DHA + EPA supplementation and intake to reduce risk of preterm birth
-
17 July 2024
Supporting the infant microbiome: Exploring the science of synergistic synbiotics at ESPGHAN 2024
-
12 July 2024
World Brain Day 2024: 3 ‘smart’ predictions that will make you re-think the future of nootropics
Latest Press Releases
-
30 August 2024
dsm-firmenich secures UK and EU approvals for 3-FL and LNFP-I/2'-FL human milk oligosaccharide ingredients
dsm-firmenich, a global innovator in health, nutrition and beauty, today announced the successful approval of its human milk oligosaccharide (HMO): 3-fucosyllactose (3-FL) and lacto-N-fucopentaose I/2'-fucosyllactose (LNFP-I/2'-FL) mixture as novel food ingredients in the United Kingdom and European Union.
-
29 August 2024
dsm-firmenich Announces Successful Defense of Patent Protecting Its Medical-Grade Colored Yarn Products
dsm-firmenich announces that the United States Patent and Trademark Office (USPTO) rejected Honeywell’s request for inter partes review (IPR) and cancellation of dsm-firmenich’s U.S. Patent No. 10,280,532, claiming a colored multi-filament yarn. The protected inventions are useful in medical devices, such as colored Ultra High Molecular Weight Polyethylene (UHMWPE) sutures.
-
15 July 2024
dsm-firmenich Announces Paul Spencer as new President of Biomedical Business
Following an extensive global search process conducted by Legacy MEDSearch, dsm-firmenich is thrilled to announce the appointment of Paul Spencer as the new President of the Biomedical business. Spencer will replace former President, John Witkowski.
How can we help you?
-
New product concept
Got a notion for your next project or breakthrough innovation? Let’s put our heads together.
-
Sample request
Don’t just take our word for it. Discover how our solutions can support your product development journey.
-
-
Quick links
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
Solutions to address consumers' health and lifestyle needs, giving you an edge in the market.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.